Tetra Tech, Inc. (TTEK) Tops Q2 EPS by 2c; Raises FY12 Outlook
Tweet
Share
E-mailGet Alerts TTEK Hot Sheet
Price: $36.43 --0%
Financial Fact:
Selling, general and administrative expenses: -47.36M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Selling, general and administrative expenses: -47.36M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Tetra Tech, Inc. (NASDAQ: TTEK) reported Q2 EPS of $0.35, $0.02 better than the analyst estimate of $0.33. Revenue for the quarter came in at $476.9 million versus the consensus estimate of $471.8 million.
Tetra Tech, Inc. sees Q3 2012 EPS of $0.42-$0.45, versus the consensus of $0.44. Tetra Tech, Inc. sees Q3 2012 revenue of $500-$540 million, versus the consensus of $528.6 million.
Tetra Tech, Inc. sees FY2012 EPS of $1.59-$1.66, versus the consensus of $1.62. Tetra Tech, Inc. sees FY2012 revenue of $2.0-$2.1 billion, versus the consensus of $2.02 billion.
For earnings history and earnings-related data on Tetra Tech, Inc. (TTEK) click here.
Tetra Tech, Inc. sees Q3 2012 EPS of $0.42-$0.45, versus the consensus of $0.44. Tetra Tech, Inc. sees Q3 2012 revenue of $500-$540 million, versus the consensus of $528.6 million.
Tetra Tech, Inc. sees FY2012 EPS of $1.59-$1.66, versus the consensus of $1.62. Tetra Tech, Inc. sees FY2012 revenue of $2.0-$2.1 billion, versus the consensus of $2.02 billion.
For earnings history and earnings-related data on Tetra Tech, Inc. (TTEK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fox upgraded to overweight as Roku deal, ad strength lift outlook
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Nkarta Inc. (NKTX) PT Lowered to $10 at Stifel as Ntrust-1/2 Trial Enrollment Progresses
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
